AI-Designed Molecular Sensors Could Transform Early Cancer Detection
Advances could signal changes for clinical laboratories and at-home testing
Already a member? Log in here
Diagnostics Pipeline: MyOme and Artera Launch New Tests for Prostate Cancer Risk
The two assays identify threats prior to prostate cancer being diagnosed and after it has undergone extensive treatment, respectively
Already a member? Log in here
Dx Deals: Seeking Expanded MRD Testing, Natera Acquires Foresight Diagnostics in $450M Deal
Agreement is part of the Natera’s aggressive growth model as it strives to turn a profit
Already a member? Log in here
Lab Directors Should Follow cfDNA Testing Progress in Ongoing Study
AMP Annual Meeting attendees showed strong interest in the blood test
Already a member? Log in here
Diagnostics Pipeline: SimplyTest, Becton Dickinson Expand HPV Testing Capabilities
SimplyTest’s saliva-based HPV tests will be marketed to dentists and functional medicine practices
Already a member? Log in here